人血中10种常见毒品的GC-MS同时检测方法研究

建立了同时检测人血液中鸦片类、巴比妥类和苯二氮卓类10种常见毒品的气相色谱-质谱新方法。系统地对提取溶剂及其组成配比、体系pH值、超声振荡提取时间等样品预处理条件以及色谱柱等GC-MS分析条件进行考察和优化。运用选择离子模式(SIM)检测,每种成分选择4个特征离子。所选的离子分别为:摇头丸m/z44、77、136、207;异戊巴比妥m/z156、55、141、41;司可巴比妥m/z168、97、195、41;咖啡因m/z194、82、109、67;安眠酮m/z235、213、250、91;美沙酮m/z72、57、165、213;吗啡m/z271、150、201、81;安定m/z256、221、283、165;氯氮平m/z243、227、256、192;艾司唑仑m/z207、239、293、259,其中黑斜体为定量离子。在选定的条件下,异戊巴比妥等7种药物在0.10~25.0 mg/L范围内线性关系良好,安定等3种药物在0.50~25.0 mg/L范围内线性关系良好,方法回收率在96%~103%之间,RSD在1.64%~6.32%之间,检出限为0.01~0.05 mg/kg。本文同时研究了pH值对吗啡类药物的影响机理。与文献报道的检测方法比较,本法更加简便易行,灵敏度提高1个数量级以上,分析时间缩短,用色谱保留时间与质谱同时定性,消除血液中其他成分干扰,结果准确可靠,选择性和重复性好,可应用于中毒患者体液样品及毒物成分的分析检测。     

Bifunctional solid catalysts for chemoselective hydrogenation-cyclisation-amination cascade reactions of relevance for the synthesis of pharmaceuticals

The benzodiazepines olanzapine and clozapine are nowadays manufactured by a three-step process with a final yield below 50%. An approach to environmentally-friendly intensive processes consists in the development of multifunctional solid catalyst able to catalyze multistep reactions. Here, a bifunctional metal-acid solid catalyst has been prepared and is able to carry out hydrogenation-cyclisation-amination reactions in a cascade process. The catalytic system is illustrated for the synthesis of these important antipsychotics, being an alternative for the current industrial process that requires three steps batch reactions, using mineral acids and bases, and stoichiometric amounts of SnCl₂.     

Etude Electrochimique et Differenciation de Derives des Dibenzodiazepines et des Dibenzothiazepines

Abstract

New psychotropic drugs like Clozapin and Clothiapin were separated and differenciated using D.C., A.C. and D.P.P. polarographic techniques. The mechanism of the electrode reaction is elucidated.     

Determination of clozapine in human plasma by solid-phase extraction and liquid chromatography with amperometric detection

Summary A sensitive and selective high-performance liquid chromatographic method has been developed for monitoring clozapine levels in human plasma. Chromatography was performed on a reversed-phase column (C₈, 150 mm×4.6 mm i.d., 5 μm) with acetonitrile-aqueous sodium acetate solution, 88∶12 (v/v), as mobile phase; the flow rate was 1 mL min⁻¹. Clozapine oxidation at +800 mV was detected amperometrically. Response was linearly dependent on concentration over the range 50–1500 ng mL⁻¹ clozapine in plasma. Sample preparation by solid-phase extraction before HPLC analysis gave high extraction yield (94%). The accuracy and precision of the method were both very good (recovery: 97%;RSD<3.3%).     

Development and validation of an HPLC method for the simultaneous determination of clozapine and desmethylclozapine in plasma of schizophrenic patients

Summary A high-performance liquid chromatographic method with amperometric detection has been developed for the determination of levels of clozapine (CLZ) and its active metabolite N-desmethylclozapine (DMC) in human plasma. The analysis was performed on a 5 μm C8 reversed phase column (150×4.6 mm i.d.), with acetonitrile-phosphate buffer (pH 3.5), as the mobile phase. The detection voltage was +800 mV and the cell and column temperature were 50°C. Linear responses were obtained between 2 ng mL⁻¹ and 100 ng mL⁻¹. Absolute recovery for both clozapine and desmethylclozapine exceeded 88% and the detection limit was 1 ng mL⁻¹. Repeatability, intermediate precision and accuracy were satisfactory. The method, which is rapid, sensitive and selective, has been applied to therapeutic drug monitoring in schizophrenic patients following administration of Leponex^? tablets. In 21 patients in steady state at a mean daily clozapine dosage of 358 mg (ranging from 150 to 500 mg day⁻¹), clozapine levels averaged 379 ng mL⁻¹ (ranging from 102 to 818 ng mL⁻¹) and DMC levels averaged 233 ng mL⁻¹ (ranging from 70 to 540 ng mL⁻¹). The method requires only a very small amount of plasma (100 μL), and thus it is suitable for pharmacokinetic studies, as well as for therapeutic drug monitoring.     

在线固相萃取-高效液相色谱法同时测定人血清中氯氮平、奎硫平和利培酮的含量

使用双梯度液相色谱系统紫外检测器,建立了在线固相萃取液相色谱法全自动、快速、同时测定人血清中氯氮平、奎琉平和利培酮的含量。本方法采用了反相系统,为了提高分离的互补性,使用Capcell MF Ph-1柱作为在线固相萃取柱,Acclaim C18柱作为分析柱。在线固相萃取柱以乙腈-水体系作为流动相,流速1 m L/min梯度洗脱;分析柱以乙腈-100 mmol/L醋酸铵溶液作为流动相,流速1 m L/min,梯度洗脱。样品溶液注入到在线固相萃取苯基柱中,根据此柱的限进机制,血清中的蛋白等大分子物质不被保留而排出,而氯氮平、奎琉平和利培酮等小分子化合物得到保留;通过阀切换使用双梯度液相色谱系统的分析泵将固相萃取柱上保留的氯氮平、奎琉平和利培酮等小分子化合物转移到分析柱中进行二次分离,采用外标法测定氯氮平、奎琉平和利培酮的含量,整个前处理和分析过程仅需18 min。氯氮平在10~1800μg/L浓度范围内相关系数为0.9996,低、中、高浓度的平均回收率分别为118.4%,105.0%和105.4%;奎琉平在3.6~640μg/L浓度范围内相关系数r为0.9997,低、中、高浓度的平均回收率分别为112.8%,101.1%和101.5%;利培酮在0.71~128μg/L浓度范围内相关系数为0.9995,低、中、高浓度的平均回收率分别为100.7%,97.2%和98.8%。结果表明,本方法可极大地提高样品分析效率,快速准确测定人血清中氯氮平、奎琉平和利培酮的含量。     

Sensitive detection of clozapine using a gold electrode modified with 16-mercaptohexadecanoic acid self-assembled monolayer

Clozapine, an effective antipsychotic drug, was found generating a pair of redox peaks at about 0.33-0.4 V (versus SCE) at 16-mercaptohexadecanoic acid (i.e. MHA) self-assembled monolayer (SAM) modified gold electrode (i.e. MHA/Au) in 0.05 mol L⁻¹ Tris-HCl (pH 8.1) buffer solution. Sensitive and quantitative measurement of clozapine based on anodic peak was established under optimum conditions. The anodic peak current was linear to clozapine concentration in the range from 1 × 10⁻⁶ to 5 × 10⁻⁵ mol L⁻¹ with the detection limit of 7 × 10⁻⁹ mol L⁻¹. This method was successfully applied to the detection of clozapine in drug tablets and proved to be reliable compared with ultraviolet spectrophotometry (UV). The MHA SAM was characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray photoelectron spectroscopy (XPS), contact angle goniometry, electrochemical impedance spectroscopy (EIS) and electrochemical probe.     

Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry

Combining electrochemical conversion, liquid chromatography and electrospray ionization mass spectrometry (EC/LC/ESI-MS) on-line allows the rapid identification of possible oxidation products of clozapine (CLZ) in the absence and in the presence of glutathione. CLZ is, depending on the applied potential, oxidized to various products in an electrochemical flow-through cell using a porous glassy carbon working electrode. Several hydroxylated and demethylated species are detected on-line using LC/MS. While hydroxy-CLZ is most abundant at a potential of 400 mV, demethylation occurs more readily at higher potentials (at around 700 mV versus Pd/H₂ reference). In the presence of glutathione (GSH), various isomeric glutathione adducts and respective products of further oxidation can be identified. The thioadducts are characterized by tandem MS. Mono-GSH and bis-GSH derivatives can be seen in the chromatograms. The results correlate well with the cyclic voltammetric profile of CLZ. The data are relevant from a pharmacological point of view, since similar metabolites (phases I and II) have been reported in the literature. The EC/LC/MS and EC/MS methods should be valuable tools that can be used to anticipate and understand the metabolization patterns of molecules of pharmacological interest and to point out reactive intermediates.     

柱前衍生化高效液相色谱法测定氯氮平中肼含量

建立了柱前衍生高效液相色谱法准确测定氯氮平中游离肼的含量.该方法以对二甲氨基苯甲醛为衍生试剂,将游离肼衍生化为对二甲氨基苄连氮,然后进行高效液相色谱测定.采用Inertsil ODS-3色谱柱(250 mm×4.6 mm,5 μm)分离,以体积分数0.1％磷酸水溶液和乙腈为流动相进行梯度洗脱,检测波长为480 nm,流...     

Quantitative determination of clozapine in serum by instrumental planar chromatography

An instrumental planar chromatographic (HPTLC) method for quantitative analysis of clozapine in human serum was developed and validated. Clozapine was extracted with n-hexane-isoamyl alcohol (75:25 v/v). The chromatographic separation was achieved on precoated silica gel F 254 HPTLC plates using a mixture of chloroform and methanol (9:1 v/v) as mobile phase. Quantitative analyses were carried out by densitometry at a wavelength of 290 nm. The method was linear between 10 and 100 ng/spot, corresponding to 0.10 and 1.00 ng/microL of clozapine in human serum after extraction process and applying 10 microL to the chromatographic plates. The method correlation coefficient was 0.999. The intra-assay variation was between 2.10 and 3.33% (n = 5) and the interassay was between 2.67 and 4.44% (n = 9). The detection limit was 0.03 ng/microL, and the quantification limit was 0.05 ng/microL. The method proved to be accurate, with a recovery between 97.00 and 99.00%, with an RSD not higher than 7.22%, and was selective for the active principle tested. This method was successfully applied to quantify clozapine in patient serum samples. In conclusion, the method is useful for the quantitative determination of clozapine in serum.